Skip to main content
letter
. 2021 Oct 19;205(1):126–129. doi: 10.1164/rccm.202108-1903LE

Table 1.

Patient Characteristics and Data at the Time of CPET

  Value
Demographics  
 Age, yr, mean ± SD 50 ± 15
 Sex, F, n (%) 35 (70)
 BMI, kg m−1, mean ± SD 26 ± 5
Comorbidities, n (%)  
 Asthma 12 (24)
 CAD 4 (8)
 COPD 2 (4)
 Diabetes mellitus 2 (4)
 Hypertension 14 (28)
 ILD 2 (4)
Smoking status, n (%)  
 Former 10 (2)
 Never 40 (80)
Medications, n (%)  
 ACE inhibitor/ARB 8 (16)
 BB 5 (10)
 CCB 1 (2)
COVID-19 clinical characteristics  
 Time from diagnosis to CPET, mean ± SD, mo 6 ± 4
 Hospital admission, n (%) 5 (10)
 ICU admission, n (%) 3 (6)
 Mechanical ventilation, n (%) 3 (6)
Post–COVID-19 symptoms, n (%)  
 Two or more of the following 6 (12)
 Dyspnea on exertion 28 (56)
 Decreased endurance 13 (26)
 Chest pain 3 (6)
Testing results  
 CT chest, n (%) 41 (82)
  Time from CT chest to CPET, mean ± SD, mo 1 ± 2
  Normal findings, n (%) 14 (34)
  Minimal GGO, n (%) 10 (24)
  Bronchial wall thickening, n (%) 13 (32)
  Peripheral reticulation, n (%) 1 (2)
 Pulmonary function test, n (%) 50 (100)
  Time from PFT to CPET, mean ± SD, mo 1 ± 2
  FVC, L; FVC % predicted, mean ± SD 3.8 ± 1; 96 ± 14
  FEV1, L; FEV1% predicted, mean ± SD 3.1 ± 0.9; 98 ± 13
  FEV1/FVC, %, mean ± SD 95 ± 12
  TLC, L; TLC % predicted, mean ± SD 5.9 ± 1.3; 103 ± 13*
  RVol, L; RVol % predicted, mean ± SD 2.2 ± 0.6; 108 ± 21*
  DlCOcor mL min-1 mm Hg; DlCOcor % predicted, mean ± SD 26 ± 8; 109 ± 22
 Echocardiography at rest, n (%) 39 (78)
  Time from echocardiogram to CPET, mean ± SD, mo 2 ± 3
  Normal LV ejection fraction, n (%) 39 (100)
  Grade 1 RV diastolic dysfunction, n (%) 2 (5)
  RV systolic dysfunction, n (%) 8 (21)
  RVSP, mean ± SD, mm Hg 38 ± 3
 MPS at rest, n (%) 8 (16)
  Time from CPET to MPS, mean ± SD, d 10 ± 90
  Normal, n (%) 8 (100)
 C-MRI at rest, n (%) 9 (18)
  Time from CPET to C-MRI, mean ± SD, mo 1 ± 3
CPET  
 Reason for discontinuation of CPET, n (%)  
  Dyspnea 20 (40)
  Overall fatigue 15 (30)
  Leg fatigue 11 (22)
  Lightheadedness 2 (4)
  Chest pain 2 (4)
 Dyspnea, Borg score, mean ± SD 8 ± 1
 Leg fatigue, Borg score, mean ± SD 8 ± 2
 WR max, Watts; % predicted, mean ± SD 144 ± 49; 95 ± 22
V˙o2 max, L min−1; % predicted, mean ± SD 1.6 ± 0.4; 95 ± 28
V˙o2 max/BW, ml kg min−1; % predicted, mean ± SD 22.2 ± 6.0; 94 ± 29
V˙co2 max, L min−1; % predicted, mean ± SD 2.0 ± 0.5; 95 ± 26
 RER, mean ± SD 1.2 ± 0.1
V˙e max, L min−1, mean ± SD 77 ± 19
 Vd/Vt, mean ± SD 0.2 ± 0.1
 HR max, beats min−1, mean ± SD 155 ± 22
 HRR, beats min−1, mean ± SD 16 ± 14
 SpO2, % mean ± SD 94 ± 4
 Lactate at peak, mmol L−1, mean ± SD 10 ± 3
 Anaerobic threshold, %, mean ± SD 51 ± 16
 Oxygen pulse, ml beat; % predicted, mean ± SD 11 ± 3.8; 99 ± 33
 SBP; DBP, mm Hg, mean ± SD 169 ± 25; 81 ± 13

Definition of abbreviations: ACE = angiotensin-converting enzyme; ARB = angiotensin receptor blocker; BB = β-adrenergic receptor antagonist; BMI = body mass index; CAD = coronary artery disease; COVID-19 = coronavirus disease; CCB = calcium channel blocker; C-MRI = cardiac magnetic resonance imaging; COPD = chronic obstructive pulmonary disease; CPET = cardiopulmonary exercise testing; CT = computed tomography; DBP = diastolic blood pressure; DlCOcor = DlCO corrected for altitude; GGO = ground glass opacifications; HR max = maximum heart rate; HRR = heart rate reserve; ILD = interstitial lung disease; LV = left ventricle; MPS = myocardial perfusion scan; PFT = pulmonary function test; RER = respiratory exchange ratio; RVol = residual volume; RV = right ventricle; RVSP = right ventricular systolic pressure; SBP = systolic blood pressure; SpO2 = oxygen saturation as measured by pulse oximetry; Vco2 max = exhaled maximum V˙co2; V˙o2 max = maximum V˙o2; V˙o2 max/BW = maximum Vo2 per kilogram body weight; WR max = maximum work rate.

N = 50.

*

n = 38.

n = 41.

n = 39.